Table 1 Patient characteristics Patient... | American Society of Hematology

Table 1

Patient characteristics

Patient no.	Subtype	Karyotype	Age at diagnosis, y	Sex	Disease status at biopsy	MRD risk status†
1	c-ALL	46XX	5	F	Diagnosis	ND
2	c-ALL	46XY	6	M	Diagnosis	ND
3	Pre-B	t(4;11), +X	0.6	M	Diagnosis	ND
4	Pre-B	-9	7	F	Diagnosis	High
5	c-ALL	t(12;21), −3, −6, +10	5	F	Diagnosis	Low
6	Pro-B	t(4;11)	0.5	F	Relapse	High
7	Pre-B*	+21, +22	3	M	Diagnosis	Low
8	c-ALL	-12p	15	M	Diagnosis	High
9	c-ALL	t(12;21), −12p	6	M	Diagnosis	IM
10	c-ALL	t(12;21)	6	M	Diagnosis	Low
11	c-ALL	t(8;21), +9	19	F	Relapse	High
12	Pre-B	Complex	14	M	Diagnosis	Low
13	c-ALL	46XX	4	F	Diagnosis	Low
14	Pro-B	t(12;17)	14	F	Diagnosis	High
15	c-ALL	t(12;21)	4	F	Diagnosis	Low
16	c-ALL	Hyperdiploid	3	F	Diagnosis	Low
17	Pro-B	t(4;11)	0.8	F	Diagnosis	High
18	c-ALL	i(9), del(9)	16	M	Relapse	Low
19	c-ALL	+7, +9, −12, (iAMP21)	8	F	Diagnosis	High
20	c-ALL	+3	14	F	Diagnosis	High
21	Pre-B	t(12;21)	8	F	Diagnosis	High
22	Pre-B	Hyperdiploid	3	M	Relapse	Low
23	Pre-B	del 1	2	F	Diagnosis	Low
24	Pre-B	Hyperdiploid	2	M	Diagnosis	Low
25	Pre-B	+14	2	F	Diagnosis	Low
26	Pre-B	t(1;19)	14	M	Diagnosis	Low
27	Pre-B	t(9;22)	15	M	Diagnosis	Low
28	Pre-B	46XY	9	M	Diagnosis	High
29	T-ALL	+4, +9	15	M	Diagnosis	High
30	T-ALL	t(11;14)	2	M	Relapse	Low
31	T-ALL	-9p, +9q	6	M	Diagnosis	High
32	T-ALL	+7, −9, t(9;16)	5	M	Diagnosis	High
33	T-ALL	t(1;14), −6	10	M	Diagnosis	Low
34	T-ALL	46XY	14	M	Diagnosis	High
35	T-ALL	t(6;7)	1	M	Diagnosis	High
36	T-ALL	-6	15	M	Diagnosis	High
37	T-ALL	46XY	13	M	Diagnosis	High

Patient no.	Subtype	Karyotype	Age at diagnosis, y	Sex	Disease status at biopsy	MRD risk status†
1	c-ALL	46XX	5	F	Diagnosis	ND
2	c-ALL	46XY	6	M	Diagnosis	ND
3	Pre-B	t(4;11), +X	0.6	M	Diagnosis	ND
4	Pre-B	-9	7	F	Diagnosis	High
5	c-ALL	t(12;21), −3, −6, +10	5	F	Diagnosis	Low
6	Pro-B	t(4;11)	0.5	F	Relapse	High
7	Pre-B*	+21, +22	3	M	Diagnosis	Low
8	c-ALL	-12p	15	M	Diagnosis	High
9	c-ALL	t(12;21), −12p	6	M	Diagnosis	IM
10	c-ALL	t(12;21)	6	M	Diagnosis	Low
11	c-ALL	t(8;21), +9	19	F	Relapse	High
12	Pre-B	Complex	14	M	Diagnosis	Low
13	c-ALL	46XX	4	F	Diagnosis	Low
14	Pro-B	t(12;17)	14	F	Diagnosis	High
15	c-ALL	t(12;21)	4	F	Diagnosis	Low
16	c-ALL	Hyperdiploid	3	F	Diagnosis	Low
17	Pro-B	t(4;11)	0.8	F	Diagnosis	High
18	c-ALL	i(9), del(9)	16	M	Relapse	Low
19	c-ALL	+7, +9, −12, (iAMP21)	8	F	Diagnosis	High
20	c-ALL	+3	14	F	Diagnosis	High
21	Pre-B	t(12;21)	8	F	Diagnosis	High
22	Pre-B	Hyperdiploid	3	M	Relapse	Low
23	Pre-B	del 1	2	F	Diagnosis	Low
24	Pre-B	Hyperdiploid	2	M	Diagnosis	Low
25	Pre-B	+14	2	F	Diagnosis	Low
26	Pre-B	t(1;19)	14	M	Diagnosis	Low
27	Pre-B	t(9;22)	15	M	Diagnosis	Low
28	Pre-B	46XY	9	M	Diagnosis	High
29	T-ALL	+4, +9	15	M	Diagnosis	High
30	T-ALL	t(11;14)	2	M	Relapse	Low
31	T-ALL	-9p, +9q	6	M	Diagnosis	High
32	T-ALL	+7, −9, t(9;16)	5	M	Diagnosis	High
33	T-ALL	t(1;14), −6	10	M	Diagnosis	Low
34	T-ALL	46XY	14	M	Diagnosis	High
35	T-ALL	t(6;7)	1	M	Diagnosis	High
36	T-ALL	-6	15	M	Diagnosis	High
37	T-ALL	46XY	13	M	Diagnosis	High

IM indicates intermediate; ND, not determined; and MRD, minimal residual disease.

ALL secondary to Down syndrome.

MRD risk status at day 28.